Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Feb 16, 2024; 16(2): 72-82
Published online Feb 16, 2024. doi: 10.4253/wjge.v16.i2.72
Published online Feb 16, 2024. doi: 10.4253/wjge.v16.i2.72
Table 3 Incidence of hospitalization costs and salvage treatments after recurrence or metastasis before inverse probability of treatment weighting adjustment
| Parameter | ESD, n = 98 | Surgery, n = 220 | d-CRT, n = 16 |
| Follow up time | 40.0 (35.0-48.0) | 43.0 (34.0-53.75) | 32.5 (28.3-40.0) |
| Total cost | 25 | 100 | 130 |
| Death toll | 1 (1.0) | 19 (8.6) | 3 (18.8) |
| Recurrence | 4 (4.0) | 3 8(17.3) | 4 (25.0) |
| Salvage measures after recurrence or metastasis | Surgery (n = 3) | Surgery (n = 5) | Neoadjuvant chemo-radiotherapy (n = 1) |
| No treatment (n = 1) | Neoadjuvant radiotherapy (n = 4) | ||
| Neoadjuvant chemotherapy (n = 8) | |||
| Neoadjuvant chemo-radiotherapy (n = 15) | |||
| No treatment (n = 7) |
- Citation: Luo SA, Sun YY, Zeng YT, Huang CY. Comparative efficacy and safety between endoscopic submucosal dissection, surgery and definitive chemoradiotherapy in patients with cT1N0M0 esophageal cancer. World J Gastrointest Endosc 2024; 16(2): 72-82
- URL: https://www.wjgnet.com/1948-5190/full/v16/i2/72.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i2.72